Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

ver descrição completa

Detalhes bibliográficos
Main Authors:	A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
Formato:	Artigo
Idioma:	Russian
Publicado em:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
Colecção:	Проблемы особо опасных инфекций
Assuntos:	вирус эбола лекарственные средства экстренная профилактика и лечение вирусспецифические антитела моноклональные антитела малые интерферирующие рнк антисмысловые фосфордиамидатные морфолиновые олигомеры ebola virus hemorrhagic fever medical products emergency prophylaxis and treatment virus-specific antibodies monoclonal antibodies small interfering rna anti-sense phosphordiamidate morpholine oligomers
Acesso em linha:	https://journal.microbe.ru/jour/article/view/254

Registos relacionados

Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
Por: E. I. Kazachinskaya, et al.
Publicado em: (2015-09-01)

“CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
Por: Alexey Alekseevich Andreev, et al.
Publicado em: (2020-06-01)

Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
Por: A. A. Petrov, et al.
Publicado em: (2020-05-01)

New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
Por: A. A. Sominina, et al.
Publicado em: (2015-10-01)

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
Por: A. V. Philippova, et al.
Publicado em: (2019-10-01)

Preparations of next generation monoclonal antibodies (issues and prospects)
Por: Zh. I. Avdeeva, et al.
Publicado em: (2018-02-01)

SMALL NONCODING RNA AS PERSPECTIVE BIOMARKERS: BIOGENESIS AND THERAPEUTIC STRATIGIES
Por: V. V. Tiguntsev, et al.
Publicado em: (2016-06-01)

Obtainment of Monoclonal Antibodies and Prospects of Their Application as Basis for Immunodiagnostic Aids for Crimean-Congo Hemorrhagic Fever Virus Detection
Por: N. P. Khrapova, et al.
Publicado em: (2015-03-01)

Safety issues of monoclonal antibodies used in rheumatology
Por: A. V. Philippova, et al.
Publicado em: (2020-01-01)

The Molecular Genetic Peculiarities of Genomic Structure of Members of the <i>Ebolavirus</i> Genus
Por: A. A. Petrov, et al.
Publicado em: (2015-09-01)

Manufacturing of Hybridomas-Producers of Monoclonal Anti-Bodies to Tularemia Agent Antigens
Por: O. O. Fomenkov, et al.
Publicado em: (2015-06-01)

Study of protectivity and antigenicity of vaccine based on ' cultural Asia-1 No.2145/ Tajikistan/2011 FMD Virus
Por: D. A. Lozovoy, et al.
Publicado em: (2018-04-01)

Constructing and Medical Trials of a Monoclonal Dot-Immuno-Enzyme Test-System “DIATul-M” for Tularemia Microbe Detection
Por: N. E. Tereshkina, et al.
Publicado em: (2013-06-01)

SEROPREVALENCE OF INFECTIOUS BURSAL DISEASE VIRUS IN PRIVATE POULTRY BREEDINGS OF UKRAINE FROM 2014 TO 2016
Por: А. С. Пастиря, et al.
Publicado em: (2017-06-01)

Utilization of Immunoblotting in Studies of Epitope Targeting in Monoclonal Antibodies to Melioidosis Agent Antigen 200 kDa
Por: I. I. Korsakova, et al.
Publicado em: (2014-12-01)

Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease
Por: T. E. Sizikova, et al.
Publicado em: (2015-09-01)

Diagnosis of hepatitis c today and interpretation of infection markers
Por: T. V. Kozhanova
Publicado em: (2013-12-01)

Antidiphtheria immunity at children with allergic diseases
Por: A V Labushkina, et al.
Publicado em: (2009-12-01)

Pharmacokinetic properties of the preparations of protein origin
Por: A. A. Soldatov, et al.
Publicado em: (2018-02-01)

Development of Immune-Chromatographic Monoclonal Test-System for the Detection of <i>Yersinia pseudotuberculosis</i>, Serogroup I
Por: N. V. Bogacheva, et al.
Publicado em: (2016-06-01)

Validation of the technique aimed at the determination of FMD antibodies in liquid phase blocking sandwich Elisa
Por: N. N. Lugovskaya, et al.
Publicado em: (2018-04-01)

Возможности сочетания иммунотерапии с лучевой терапией в лечении больных неоперабельным местно-распространённым немелкоклеточным раком легкого. Обзор литературы.
Publicado em: (2021-06-01)

Сравнительная эффективность и безопасность применения препаратов моноклональных антител к ИЛ-6 у пациентов с новой коронавирусной инфекцией COVID-19 тяжелого течения. Ретроспективное когортное исследование
Por: С. С. Бобкова, et al.
Publicado em: (2021-03-01)

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review
Por: D. L. Klabukova, et al.
Publicado em: (2018-07-01)

Метод РНК-интерференции в защите растений от насекомых-вредителей
Por: Владимир Сергеевич Журавлев, et al.
Publicado em: (2022-04-01)

Validation of the XTT-test for assessing the antiproliferative activity of biologics on the basis of monoclonal antibodies
Por: I. V. Lyagoskin, et al.
Publicado em: (2018-02-01)

FREQUENCY OF OCCURRENCE OF ANTIBODIES TO HLA ANTIGENS IN RECIPIENTS ON THE WAITING LIST FOR KIDNEY TRANSPLANTATION
Por: Елена Борисовна Лукоянычева, et al.
Publicado em: (2023-02-01)

The morphological changes dynamics of ovarian reproductive apparatus in the experimental autoimmune oophoritis
Por: M. L. Dmitriyeva, et al.
Publicado em: (2012-02-01)

The Value of the Effect of the Level of Specific Antibodeis on Elimination Different Tick-Borne Encephalitis Virus Strains
Por: G. N. Leonova, et al.
Publicado em: (2017-04-01)

Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development
Por: A. A. Lidzhieva, et al.
Publicado em: (2018-02-01)

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
Por: N. T. Tikhonova, et al.
Publicado em: (2017-12-01)

Construction and Investigation of the Variants of the Vaccine Strain <I>Francisella tularensis</I> Lacking <I>iglC </I>Genes. Communication 2
Por: A. N. Mokrievich, et al.
Publicado em: (2013-12-01)

Donor – recipient selection using epitope mismatches in kidney transplantation
Por: A. V. Vatazin, et al.
Publicado em: (2021-01-01)

Improvement of Diagnostic System in a Real-Time RT-PCR “AmpliSens EBOV (ZAIRE)-FL” Format for Zaire ebolavirus RNA Detection
Por: V. G. Dedkov, et al.
Publicado em: (2015-09-01)

Construction and Approval of the Test-System for the Detection of Antibodies to Anthrax Agent Using Indirect Fluorescent Immunoassay
Por: L. Yu. Aksenova, et al.
Publicado em: (2013-12-01)

Antikeratin antibodies in rheumatoid arthritis
Por: J Zabek
Publicado em: (2003-02-01)

Заболявания, свързани с анти-миелинови олигодендроцитни гликопротеинови антитела (MOG-antibody diseases)
Por: Sonia Ivanova, et al.
Publicado em: (2019-09-01)

The possible role of toxoplasmosis in the development of antiphospholipid antibodies in pregnancy-related complications
Por: - Bayati Ali Hattem Hussein, et al.
Publicado em: (2012-09-01)

Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
Por: A. A. Lopatin, et al.
Publicado em: (2015-09-01)

Future Developments and Applications of the Vaccines against Dangerous Viral Infections, RNA-Replicon-Based, Obtained from the Venezuelan Equine Encephalomyelitis Virus
Por: A. A. Petrov, et al.
Publicado em: (2014-09-01)